Cargando…
A feline case of multiple myeloma treated with bortezomib
BACKGROUND: Multiple myeloma (MM) is an uncommon neoplasm in cats. There is no established standard of treatment due to the rare occurrence of this disease in cats. Bortezomib is a proteasome inhibitor that serves as the first-line drug for MM in humans, but its effectiveness currently is unknown in...
Autores principales: | Tani, Hiroyuki, Miyamoto, Ryo, Miyazaki, Teruki, Oniki, Shingo, Tamura, Kyoichi, Bonkobara, Makoto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632122/ https://www.ncbi.nlm.nih.gov/pubmed/36324112 http://dx.doi.org/10.1186/s12917-022-03484-1 |
Ejemplares similares
-
A canine case of malignant melanoma carrying a KIT c.1725_1733del mutation treated with toceranib: a case report and in vitro analysis
por: Tani, Hiroyuki, et al.
Publicado: (2021) -
Tumor lysis syndrome in multiple myeloma treated with bortezomib
por: Dhanraj, K. M., et al.
Publicado: (2014) -
Bortezomib in the management of multiple myeloma
por: Laubach, Jacob P, et al.
Publicado: (2009) -
A Case of Multiple Myeloma with Metachronous Chronic Myeloid Leukemia Treated Successfully with Bortezomib, Dexamethasone, and Dasatinib
por: Alsidawi, Samer, et al.
Publicado: (2014) -
Pharmacovigilance of patients with multiple myeloma being treated with bortezomib and/or thalidomide
por: Castro, T.B.M., et al.
Publicado: (2016)